Zinc and prostatic cancer

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 6, 2009, Pages 640-645

  Ho, Emily ^a,b,c   Song, Yang ^a  

^a Department of Nutrition and Exercise Science ^*  (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

DNA damage; Prostatic cancer; Zinc; Zinc transporter

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; ZINC; ZINC TRANSPORTER;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CELL CYCLE ARREST; DIET SUPPLEMENTATION; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; ENERGY YIELD; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; CATION TRANSPORT PROTEINS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; EPITHELIAL CELLS; HUMANS; MALE; MITOCHONDRIA; NF-KAPPA B; PROSTATE; PROSTATIC NEOPLASMS; ZINC;

EID: 70350134462     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32833106ee     Document Type: Review

References (53)

1. Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006; 5:17.
2. Cortesi M, Fridman E, Volkov A, et al. Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study. Prostate 2008; 68:994-1006.
3. Cortesi M, Chechik R, Breskin A, et al. Evaluating the cancer detection and grading potential of prostatic-zinc imaging: a simulation study. Phys Med Biol 2009; 54:781-796.
4. Costello LC, Franklin RB. Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem. Prostate Cancer Prostatic Dis 2009; 12:17-24.
5. Costello LC, Guan Z, Kukoyi B, et al. Terminal oxidation and the effects of zinc in prostate versus liver mitochondria. Mitochondrion 2004; 4:331-338.
6. Dubi N, Gheber L, Fishman D, et al. Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells. Carcinogenesis 2008; 29:1692-1700.
7. Costello LC, Liu Y, Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997; 272:28875-28881.
8. Costello LC, Liu Y, Zou J, Franklin RB. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem 1999; 274:17499-17504.
9. Clegg MS, Hanna LA, Niles BJ, et al. Zinc deficiency-induced cell death. IUBMB Life 2005; 57:661-669.
10. Lin SF, Wei H, Maeder D, et al. Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study. J Nutr Biochem 2008 [Epub ahead of print]
11. Feng P, Li T, Guan Z, et al. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer 2008; 7:25.
12. Feng P, Li TL, Guan ZX, et al. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002; 52:311-318.
13. Golovine K, Uzzo RG, Makhov P, et al. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Prostate 2008; 68:1443-1449.
14. Uzzo RG, Leavis P, Hatch W, et al. Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res 2002; 8:3579-3583.
15. Uzzo RG, Crispen PL, Golovine K, et al. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis 2006; 27:1980-1990.
16. Killilea AN, Downing KH, Killilea DW. Zinc deficiency reduces paclitaxel efficacy in LNCaP prostate cancer cells. Cancer Lett 2007; 258:70-79.
17. Ho E, Ames BN. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 2002; 99:16770-16775.
18. Ho E, Courtemanche C, Ames BN. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 2003; 133:2543-2548.
19. Yan M,Song Y, Wong CP, et al. Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr 2008; 138:667-673.
20. Song Y, Chung CS, Bruno RS, et al. Dietary zinc restriction and repletion affects DNA integrity in healthy men. Am J Clin Nutr 2009; 90:321-328.
21. Yousef MI, El-Hendy HA, El-Demerdash FM, Elagamy EI. Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 2002; 175:223-234.
22. Shaheen AA, el-Fattah AA. Effect of dietary zinc on lipid peroxidation, glutathione, protein thiols levels and superoxide dismutase activity in rat tissues. Int J Biochem Cell Biol 1995; 27:89-95.
23. Canali R, Vignolini F, Nobili F, Mengheri E. Reduction of oxidative stress and cytokine-induced neutrophil chemoattractant (CINC) expression by red wine polyphenols in zinc deficiency induced intestinal damage of rat. Free Radic Biol Med 2000; 28:1661-1670.
24. Bruno RS, Song Y, Leonard SW, et al. Dietary zinc restriction in rats alters antioxidant status and increases plasma F2 isoprostanes. J Nutr Biochem 2007; 18:509-518.
25. Mills BJ, Lindeman RD, Lang CA. Differences in blood glutathione levels of tumor-implanted or zinc-deficient rats. J Nutr 1981; 111:1586-1592.
26. Albrecht AL, Singh RK, Somji S, et al. Basal and metal-induced expression of metallothionein isoform 1 and 2 genes in the RWPE-1 human prostate epithelial cell line. J Appl Toxicol 2008; 28:283-293.
27. Wei H, Desouki MM, Lin S, et al. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues. Mol Cancer 2008; 7:7.
28. Clegg MS, Keen CL, Donovan SM. Zinc deficiency-induced anorexia influences the distribution of serum insulin-like growth factor-binding proteins in the rat. Metabolism 1995; 44:1495-1501.
29. Chou SS, Clegg MS, Momma TY, et al. Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death. Biochem J 2004; 383 (Pt 1):63-71.
30. IshikawaY, Kudo H, Suzuki S, et al. Down regulation by a low-zinc diet in gene expression of rat prostatic thymidylate synthase and thymidine kinase. Nutr Metab (Lond) 2008; 5:12.
31. Fanzo JC, Reaves SK, Cui L, et al. Zinc status affects p53, gadd45, and c-fos expression and caspase-3 activity in human bronchial epithelial cells. Am J Physiol Cell Physiol 2001; 281:C751-C757.
32. Lichten LA, Cousins RJ. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 2009; 29:153-176.
33. Franklin RB, Feng P, Milon B, et al. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer 2005; 4: 32.
34. Makhov P, Golovine K, Uzzo RG, et al. Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells. Gene 2009; 431:39-46.
35. Huang L, Kirschke CP, Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int 2006; 6:10.
36. Golovine K, Makhov P, Uzzo RG, et al. Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin Cancer Res 2008; 14:5376-5384.
37. Hasumi M, Suzuki K, Matsui H, et al. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett 2003; 200:187-195.
38. Iguchi K, Otsuka T, Usui S, et al. Zinc and metallothionein levels and expression of zinc transporters in androgen-independent subline of LNCaP cells. J Androl 2004; 25:154-161.
39. Beck FW, Prasad AS, Butler CE, et al. Differential expression of hZnT-4 in human prostate tissues. Prostate 2004; 58:374-381.
40. Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 2006; 17:308-314.
41. Wu T, Sempos CT, Freudenheim JL, et al. Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol 2004; 14:195-201.
42. Ito Y, Suzuki K, Sasaki R, et al. Mortality rates from cancer or all causes and SOD activity level and Zn/Cu ratio in peripheral blood: population-based follow-up study. J Epidemiol 2002; 12:14-21.
43. KristalAR, Stanford JL, Cohen JH, et al. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomar-kers Prev 1999; 8:887-892.
44. Kristal AR, Arnold KB, Schenk JM, et al. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 2008; 167:925-934.
45. Gonzalez A, Peters U, Lampe JW, White E. Zinc intake from supplements and diet and prostate cancer. Nutr Cancer 2009; 61:206-215.
46. Wagner SE, Burch JB, Hussey J, et al. Soil zinc content, groundwater usage, and prostate cancer incidence in South Carolina. Cancer Causes Control 2009; 20:345-353.
47. Zhang Y, Coogan P, Palmer JR, et al. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control 2009; 20:691-698.
48. Yadrick MK, Kenney MA, Winterfeldt EA. Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr 1989; 49:145-150.
49. Hess SY, Peerson JM, King JC, Brown KH. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr Bull 2007; 28 (3 Suppl): S403-S429.
50. Chung CS, Stookey J, Dare D, et al. Current dietary zinc intake has a greater effect on fractional zinc absorption than does longer term zinc consumption in healthy adult men. Am J Clin Nutr 2008; 87:1224-1229.
51. Block G, Jensen CD, Morrow JD, et al. The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 2008; 45:377-384
52. Centers for Disease Control and Prevention (CDC) and National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Hyattsville, Maryland; 2001-2002. http://www.cdc.gov/nchs/ about/major/nhanes/ nhan es01-02.htm.
53. Prasad AS, Bao B, Beck FW, Sarkar FH. Correction of interleukin-2 gene expression by in vitro zinc addition to mononuclear cells from zinc-deficient human subjects: a specific test for zinc deficiency in humans. Transl Res 2006; 148:325-333.